Genetic consequences of effective and suboptimal dosing with mutagenic drugs in a hamster model of SARS-CoV-2 infection (2024)

First Author: Illingworth C
Attributed to:  MRC Centre for Virus Research (MRC CVR) - COVID-19 funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1093/ve/veae001

Publication URI: http://dx.doi.org/10.1093/ve/veae001

Type: Journal Article/Review

Parent Publication: Virus Evolution

Issue: 1